#gsk — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #gsk, aggregated by home.social.
-
GSK heads to Cambridge with long-awaited positive vibes | Nils Pratley
By Nils PratleyPharmaceutical company’s move to new £400m research centre accompanied by encouraging news for shareholders
#Pharmaceuticalsindustry #GSK #UKnews #Business #Cambridge #Cambridgeshire #TheGuardian #NilsPratley
-
GSK heads to Cambridge with long-awaited positive vibes | Nils Pratley https://www.theguardian.com/business/nils-pratley-on-finance/2026/jul/28/gsk-cambridge-long-awaited-good-vibes #PharmaceuticalsIndustry #UkNews #Business #Gsk
-
GSK heads to Cambridge with long-awaited positive vibes | Nils Pratley https://www.theguardian.com/business/nils-pratley-on-finance/2026/jul/28/gsk-cambridge-long-awaited-good-vibes #PharmaceuticalsIndustry #UkNews #Business #Gsk
-
Padilha anuncia compra do cabotegravir, PrEP de longa duração
No AIDS 2026, ministro da Saúde tornou pública a aquisição do medicamento de HIV. Também informou sobre o impasse do lenacapavir e um acordo para acompanhar o desenvolvimento do alimatravirhttps://outraspalavras.net/outrasaude/padilha-anuncia-compra-do-cabotegravir-prep-de-longa-duracao/
-
GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development
By Joanna PartridgePharmaceuticals company is investing £400m in UK life sciences and moving scientists to new Cambridge R&D site
#Pharmaceuticalsindustry #GSK #Business #Biotechnologyindustry #UKnews #Science #Cambridge #Cambridgeshire #Hertfordshire #Stevenage #TheGuardian #JoannaPartridge
-
GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development https://www.theguardian.com/business/2026/jul/28/gsk-cut-jobs-cost-cutting-faster-drug-development-cambridge #PharmaceuticalsIndustry #Gsk #Business #BiotechnologyIndustry #UkNews #Science #Cambridge #Cambridgeshire #Hertfordshire #Stevenage
-
GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development https://www.theguardian.com/business/2026/jul/28/gsk-cut-jobs-cost-cutting-faster-drug-development-cambridge #PharmaceuticalsIndustry #Gsk #Business #BiotechnologyIndustry #UkNews #Science #Cambridge #Cambridgeshire #Hertfordshire #Stevenage
-
GSK to buy US cancer treatment firm Nuvalent for $10.6bn https://www.theguardian.com/business/2026/jun/09/gsk-buy-us-cancer-treatment-firm-nuvalent-luke-miels #Gsk #PharmaceuticalsIndustry #Business #UkNews #UsNews #Cancer #Society
-
Julie Bowen, Ty Burrell Find Advertisers Crave a ‘Modern Family’ Approach to Commercials
#Variety #News #GSK #JulieBowen #ModernFamily #TyBurrellhttps://variety.com/2026/tv/news/julie-bowen-ty-burrell-modern-family-commercials-1236752714/
-
Julie Bowen, Ty Burrell Find Advertisers Crave a ‘Modern Family’ Approach to Commercials
#Variety #News #GSK #JulieBowen #ModernFamily #TyBurrellhttps://variety.com/2026/tv/news/julie-bowen-ty-burrell-modern-family-commercials-1236752714/
-
Unser MEZIS-Medientipp für heute: "Negativpreis für Gürtelrose-Kampagne von Pharma-Hersteller", Frankfurter Rundschau, 20.04.26.
Und ja, der Preis ist von uns und heißt "Goldenes Zäpfchen" ;-)
-
Unser MEZIS-Medientipp für heute: "Negativpreis für Gürtelrose-Kampagne von Pharma-Hersteller", Frankfurter Rundschau, 20.04.26.
Und ja, der Preis ist von uns und heißt "Goldenes Zäpfchen" ;-)
-
GSK reports promising early results in ovarian and womb cancer drug trial https://www.theguardian.com/business/2026/apr/12/gsk-promising-early-results-ovarian-womb-cancer-drug-trial #Gsk #PharmaceuticalsIndustry #Business #UkNews #Cancer #MedicalResearch #Health #Drugs #ManufacturingSector #WomensHealth
-
GSK reports promising early results in ovarian and womb cancer drug trial https://www.theguardian.com/business/2026/apr/12/gsk-promising-early-results-ovarian-womb-cancer-drug-trial #Gsk #PharmaceuticalsIndustry #Business #UkNews #Cancer #MedicalResearch #Health #Drugs #ManufacturingSector #WomensHealth
-
Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn https://www.theguardian.com/business/2026/mar/10/new-drugs-fight-superbugs-uk-gsk-astrazeneca #PharmaceuticalsIndustry #Gsk #Astrazeneca #Business #InfectiousDiseases #MedicalResearch #Science #UkNews
-
Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn https://www.theguardian.com/business/2026/mar/10/new-drugs-fight-superbugs-uk-gsk-astrazeneca #PharmaceuticalsIndustry #Gsk #Astrazeneca #Business #InfectiousDiseases #MedicalResearch #Science #UkNews
-
Die Pharma-Firma GlaxoSmithKline (GSK) überzieht diese Tage die Republik wieder mit angsterzeugender Werbung in den Medien, z.B. mit ganzseitigen Zeitungsanzeigen die reisserisch titeln: „RSV-Saison erreicht kritische Phase“.
Werbung von Pharmafirmen in der Laienpresse ist eigentlich aus gutem Grund verboten. Ein Blick nach Amerika mit seinen hundertausenden Toten durch Werbung für Opioide sollte genügen.
Dennoch umgehen Pharmafirmen zunehmend aggressiv das Werbeverbot – wir von #MEZIS haben deswegen 2025 eine Petition in den Bundestag eingebracht.
Aktuell macht GSK prominent Werbung mit einem Arzt, Dr. Frühwein. Der Mediziner behauptet vollmundig: „Die Impfung ist eine wichtige Maßnahme um Lebensqualität zu erhalten“. Was viele nicht wissen, Dr. Frühwein betreibt auch das „Forum Impfen e.V“. Sich selbst bezeichnet der Verein als „die größte umfangreichste deutsche ...
... hier weiterlesen:
https://mezis.de/das-forum-impfen-e-v-und-die-angsterzeugende-laien-werbung-fuer-die-rsv-impfung-von-glaxosmithkline/ -
Die Pharma-Firma GlaxoSmithKline (GSK) überzieht diese Tage die Republik wieder mit angsterzeugender Werbung in den Medien, z.B. mit ganzseitigen Zeitungsanzeigen die reisserisch titeln: „RSV-Saison erreicht kritische Phase“.
Werbung von Pharmafirmen in der Laienpresse ist eigentlich aus gutem Grund verboten. Ein Blick nach Amerika mit seinen hundertausenden Toten durch Werbung für Opioide sollte genügen.
Dennoch umgehen Pharmafirmen zunehmend aggressiv das Werbeverbot – wir von #MEZIS haben deswegen 2025 eine Petition in den Bundestag eingebracht.
Aktuell macht GSK prominent Werbung mit einem Arzt, Dr. Frühwein. Der Mediziner behauptet vollmundig: „Die Impfung ist eine wichtige Maßnahme um Lebensqualität zu erhalten“. Was viele nicht wissen, Dr. Frühwein betreibt auch das „Forum Impfen e.V“. Sich selbst bezeichnet der Verein als „die größte umfangreichste deutsche ...
... hier weiterlesen:
https://mezis.de/das-forum-impfen-e-v-und-die-angsterzeugende-laien-werbung-fuer-die-rsv-impfung-von-glaxosmithkline/ -
GSK to buy food allergy drug maker RAPT in $2.2bn deal https://www.theguardian.com/business/2026/jan/20/gsk-buy-food-allergy-drug-maker-rapt-us-biotech #Gsk #PharmaceuticalsIndustry #Business #Allergies #Society #UkNews #UsNews
-
GSK to buy food allergy drug maker RAPT in $2.2bn deal https://www.theguardian.com/business/2026/jan/20/gsk-buy-food-allergy-drug-maker-rapt-us-biotech #Gsk #PharmaceuticalsIndustry #Business #Allergies #Society #UkNews #UsNews
-
Company Snapshots 🔍
2024 PEG snapshot:
📈 #NovoNordisk – growth outpacing valuation → undervalued standout.
⚖️ #Novartis, #Merck, #AstraZeneca – solid growth, but P/Es are sky-high.
🚫 #Sanofi, #GSK, #Ipsen – negative earnings growth = PEG not meaningful.PEG = P/E ÷ growth → simple in theory, tricky in practice!
(2/5)
-
2020–2024 results:
The picture splits sharply:
🟢 #Novartis: strong margin gains, signaling real efficiency wins.
🟡 #NovoNordisk: rare balance of high growth and stable margins.
🔴 #Sanofi, #GSK, #Ipsen: margin erosion despite growth.
⚪ #AstraZeneca & #Merck: steady on both fronts.(2/5)
-
2020-2024 performance:
In this period, #NovoNordisk and #AstraZeneca clearly outpaced their peers.
#GSK and #Novartis, meanwhile, struggled to expand their toplines.
The graph shows a sharp divide, with only a couple of true standouts.
(2/5)
-
Mh.
last update of #archlinux defaults to #GTK4 #GSK #Vulcan Renderer:
(note: here I'm definingGDK_BACKEND=waylandbecause the terminal is in VSCode, which runs on XWayland and define GDK_BACKEND=x11. In VSCode because gnome console was a black rectangle too)Yes, that white rectangle is the window.
I had to set
GSK_RENDERER=nglin.config/environment.d/gtk4.conf -
Mh.
last update of #archlinux defaults to #GTK4 #GSK #Vulcan Renderer:
(note: here I'm definingGDK_BACKEND=waylandbecause the terminal is in VSCode, which runs on XWayland and define GDK_BACKEND=x11. In VSCode because gnome console was a black rectangle too)Yes, that white rectangle is the window.
I had to set
GSK_RENDERER=nglin.config/environment.d/gtk4.conf -
Les patrons de #NovoNordisk #pfizer #elililly #roche #sanofi #merck #GSK ou encore #Servier menacent de retirer des investissements d’ #Europe Ils demandent de «raccourcir le processus pour les essais cliniques menés dans plusieurs pays» «suspendre et réviser la mise en œuvre» d’une directive qui vise à améliorer le traitement des eaux usées avant leur rejet dans la nature... https://www.ouest-france.fr/europe/ue/des-laboratoires-pharmaceutiques-menacent-de-retirer-des-investissements-deurope-5d860c16-1a2a-11f0-a759-74724e64dd56
-
Les patrons de #NovoNordisk #pfizer #elililly #roche #sanofi #merck #GSK ou encore #Servier menacent de retirer des investissements d’ #Europe Ils demandent de «raccourcir le processus pour les essais cliniques menés dans plusieurs pays» «suspendre et réviser la mise en œuvre» d’une directive qui vise à améliorer le traitement des eaux usées avant leur rejet dans la nature... https://www.ouest-france.fr/europe/ue/des-laboratoires-pharmaceutiques-menacent-de-retirer-des-investissements-deurope-5d860c16-1a2a-11f0-a759-74724e64dd56
-
Risposta Contro la Discriminazione Promossa da Glaxo
https://mailchi.mp/207c6d929a41/in-distribuzione-delta-18233489?e=4a2a3e61f6
> ...contro la decisione di #GLAXO #SMITHKLINE ( #GSK ) di sospendere ogni attività di ricerca e sviluppo di terapie per le persone che intendono iniziare, continuare, terminare l’adattamento del proprio genere.
-
Interesting: Canada is buying 500,000 doses of #GSK 's #H5N1 vaccine "as part of ... contingency planning to protect people who may be at increased risk of being exposed to the virus through [infected] animals."
Wonder what would trigger a decision to use it?
https://www.canada.ca/en/public-health/news/2025/02/government-of-canada-purchases-avian-influenza-vaccine-to-protect-individuals-most-at-risk.html -
Interesting: Canada is buying 500,000 doses of #GSK 's #H5N1 vaccine "as part of ... contingency planning to protect people who may be at increased risk of being exposed to the virus through [infected] animals."
Wonder what would trigger a decision to use it?
https://www.canada.ca/en/public-health/news/2025/02/government-of-canada-purchases-avian-influenza-vaccine-to-protect-individuals-most-at-risk.html -
After some trial-and-error I finally managed to wrap my around how to make a radial gradient effect using GSK for new redesigned current location widget (showing a "heading torch")
-
After some trial-and-error I finally managed to wrap my around how to make a radial gradient effect using GSK for new redesigned current location widget (showing a "heading torch")
-
#BBCNews - UK firm #GSK to pay $2.2bn over #Zantac cancer claims
https://www.bbc.com/news/articles/c62r5nn94d7o -
#BBCNews - UK firm #GSK to pay $2.2bn over #Zantac cancer claims
https://www.bbc.com/news/articles/c62r5nn94d7o -
By 2019 popular non prescription #heartburn #medication #Zantac was recalled from retail after it was found to contain an #antihistamine that blocks the release of stomach acid called N-nitrosodimethylamine (#NDMA) that is linked to causing #cancer.
#Drug Mfgr #GSK has reached $2.2bn #legalsettlement in US that is supposed to cover 93% of user cases brought thus far.
Previously #GlaxoSmithKline had paid $70m to settle with the lab that discovered the issue, and other big #drugmakers that also marketed the #OTC drug, including #Pfizer and #Sanofi, have already reached sizable settlements.
https://on.ft.com/4eBVq5g #FinancialTimes #GiftLink #Legal #ProductLiability
-
Addictions au sexe et aux jeux: des malades de Parkinson s’estiment floués par un labo
Un traitement consommé par 48 000 personnes atteintes en France de la #MaladieDeParkinson provoque de graves effets indésirables: sexualité compulsive, achats frénétiques et dépendance aux jeux. Une victime poursuit #GSK, le fabricant du Requip.
-
Addictions au sexe et aux jeux: des malades de Parkinson s’estiment floués par un labo
Un traitement consommé par 48 000 personnes atteintes en France de la #MaladieDeParkinson provoque de graves effets indésirables: sexualité compulsive, achats frénétiques et dépendance aux jeux. Une victime poursuit #GSK, le fabricant du Requip.
-
European Stocks rise 1% led by #ASML's 8% surge on U.S. rule exemption. Airbus +5.2%, #Safran +1.1%, #HSBC +3%, #SchneiderElectric +3.4%, #WoltersKluwer -6%, GSK -1%. #Europe #Stocks #Airbus #HSBC #GSK
-
European Stocks rise 1% led by #ASML's 8% surge on U.S. rule exemption. Airbus +5.2%, #Safran +1.1%, #HSBC +3%, #SchneiderElectric +3.4%, #WoltersKluwer -6%, GSK -1%. #Europe #Stocks #Airbus #HSBC #GSK
-
5 neuro data readouts to watch in the second half of 2024 — GSK moves to new HQ in return to central London — AbbVie led the way in paying doctors to pitch its drugs last year —http://bit.ly/w28kSd #clinicaltrials #neurology #gsk #london #abbvie #physicians #physicianpayments #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
#EuropeanStocks climb as Powell signals progress on inflation at ECB event. UK, France prep for elections amid market scrutiny. #GSK buys mRNA vaccine rights, #Vodafone (VOD) rises on network deal. #Oil prices up on US inventory draw. #StockMarket #Powell #EUelections
-
#EuropeanStocks climb as Powell signals progress on inflation at ECB event. UK, France prep for elections amid market scrutiny. #GSK buys mRNA vaccine rights, #Vodafone (VOD) rises on network deal. #Oil prices up on US inventory draw. #StockMarket #Powell #EUelections
-
#US stock #futures slip, driven by tech sector losses. #Micron drops 6%, #LeviStrauss down 16%, #Walgreens falls 4.8%, #GSK dips 1.8%, #Uber 0.2% lower, International Paper plunges 14%, #AeroVironment drops 7.1%, #Rivian dips 1.4%.
-
GSK shares drop 6% as CDC limits RSV vaccine to high-risk ages 60-74. Impact on Arexvy's blockbuster potential. Stock recovers to -4.4%. UBS maintains Buy rating due to strong future sales from Shingrix and Cabenuva. #GSK #RSVVaccine #Pharma
-
#FDA has expanded the approval of #GSK's #RSV vaccine for adults, opening up its use in people 50 and older. Previously the vaccine, sold as Arexvy, was approved for use in adults 60 and older. https://www.statnews.com/2024/06/07/gsk-rsv-vaccine-fda-expanded-approval-cdc-arexvy/
